Sentence examples for approach we treated from inspiring English sources

As an alternative approach, we treated HeLa cells with XIE62-1004 and performed the in vivo filter trap assay of cellular proteins which are insoluble in 1% Triton X-100, which showed the co-aggregation of p62 along with Ub-conjugated protein species (Fig. 4g).

In a first approach we treated HUVECs with lipoproteins and initiated apoptosis when lipoproteins were cleaved by LPL [3].

In the first approach, we treated CHO cells with DRB or DMSO for 10 min, then pulsed cells with bromo-uridine (BrU) to label newly-synthesized RNA (an in vivo RNA run-off assay).

Using a molecular approach, we treated the KDΔ4 cells with TGF-ß and found that TGF-ß could no longer stimulate Gli2 (Figure 6E) or PTHrP (Figure 6F), thus suggesting that ROCK is required for TGF-ß to stimulate Gli2 and PTHrP.

In an additional approach, we treated primary neurons from wildtype mice with pharmacological compounds that either enhanced or inhibited autophagy.

To validate this in vivo screening approach, we treated KIC mice with gemcitabine+Abraxane (GA), a current standard-of-care for PDA therapy (Von Hoff et al., 2013).

However, in our approach, we treat each subimage as a point in a high-dimensional space rather than a two-dimensional matrix as in SVD hashing [14] and NMF hashing [16].

For the first approach we treat each frequency/altitude combination as independent, so for notational simplicity we write out the models as y k (d) and we ask the reader to remember that each of these models is run independently for each frequency/altitude combination.

For example, when we say 'the holidays are approaching', we treat the holidays as if they were looming objects (compare the syntactically equivalent 'the children are approaching') [ 20].

We used ordinary least squares (OLS) regression with the confounders previously described controlled for, but because OLS estimates may be subject to residual confounding by other, unobserved factors that are correlated with both growth and the outcomes (24– 26), we also used an IV approach, whereby we treated HAZ (or stunting) as endogenous.

To confirm these effects with an independent loss of function approach, we also treated WT mice with zileuton, a leukotriene antagonist.